Volume 5, Number 6 (June 2007)

Bench to Bedside

259

Chemotherapy-Induced Mucositis: The Role of Gastrointestinal Microflora and Mucins in the Luminal Environment
Andrea M. Stringer, BAppSc (Hons), Rachel J. Gibson, PhD, Joanne M. Bowen, PhD, Richard M. Logan, BDS MDS, Ann S-J Yeoh, BMEDSc, and Dorothy M.K. Keefe, MD, FRACP

Department of Medical Oncology, Royal Adelaide, Hospital; the Department of Medicine and the School of Dentistry, The University of Adelaide; and the Division of Tissue Pathology, Institute of Medical and Veterinary Science, South Australia

abstract

full text

254 kb

PEER VIEWPOINT
Chemotherapy-Induced Mucositis: Focusing on Diarrhea
Kari Wisinski, MD, and Al Benson III, MD, FACP, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois

full text

67 kb

Original Research

273

Use of Heparin-Coated Central Venous Lines to Prevent Catheter-Related Bloodstream Infection
Abderrahman Abdelkefi , MD, Wafa Achour, MD, Tarek Ben Othman, MD,Saloua Ladeb, MD, Lamia Torjman, MD, Amel Lakhal, MD, Assia Ben Hassen, MD, Mohamed Hsairi, MD, and Abdeladhim Ben Abdeladhim, MD

Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia, and Institut National de la Santé Publique, Tunis, Tunisia

abstract

full text

118 kb

281

Patients’ and Doctors’ Views of Using the Schedule for Individual Quality of Life in Clinical Practice
Åsa Kettis-Lindblad, PhD, Lena Ring, PhD, Elisabeth Widmark, MSc (Pharm), Preben Bendtsen, MD, and Bengt Glimelius, MD

Department of Pharmacy, Uppsala University, Uppsala, Sweden; Department of Health and Society, Social Medicine and Public Health, Linköping, Sweden; Department of Oncology, Radiology, and Clinical Immunology, Uppsala University, Uppsala, and Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden

abstract

full text

169 kb

How We Do It

289

Achieving Analgesia for Painful Ulcers Using Topically Applied Morphine Gel
Quy N.H. Tran, MD, and Tonya Fancher, MD

Department of Internal Medicine, University of California at Davis, Medical Center, Sacramento, California

full text

172 kb

Letter to the Editor

256

Thalidomide in Combination With Dexamethasone-Induced Rhabdomyolysis in a Patient With Refractory Myeloma
Can Boga, MD, Hakan Ozdogu, MD, Mahmut Yeral, MD, Ebru Kizilkilic, MD, and Lulufer Tamer, MD

Department of Hematology, Baskent University Faculty of Medicine, Ankara, and Department of Biochemistry, Mersin University Faculty of Medicine, Mersin, Turkey

full text

50 kb

© 2007 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without written permission from the publisher.

The opinions expressed herein are those of the authors or advertisers. The authors, editors, and publishers make every effort to ensure that no inaccurate or misleading data, opinion, or statement is published in this journal and that drug names, dosages, and recommendations are accurate. However, readers should confirm all dosage schedules against the manufacturer’s package information data. The Publisher, Editorial Board, and their employees accept no liability whatsoever for the consequences of any inaccurate or misleading data, opinion, or statement.